RECURMDX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 10 Aug 2023)
What this means for you
Registered since 21 Feb 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal is due by 21 Feb 2027, and its filing window is open now).
Record
- Serial number
- 85774298
- Registration number
- 5146876
- Mark type
- Word mark
- Filed
- 08 Nov 2012
- Published for opposition
- 16 Apr 2013
- Registered
- 21 Feb 2017
- Next maintenance filing
- §8 & §9 renewal, due by 21 Feb 2027 (grace period to 21 Aug 2027)
- Attorney of record
- Neal Wolgin
Goods and services
- Class 042 — Scientific and technological services: Clinical and medical laboratory testing services in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom assay development; pharmaceutical drug discovery and development services
Owner
- MDXHealth S.A., Liege 4000, BE
- MDXHealth S.A., Liege 4000, BE
- MDXHealth S.A., Liege 4000, BE
Prosecution history
- 21 Feb 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 10 Aug 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 Aug 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Aug 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Feb 2023 — TEAS SECTION 8 & 15 RECEIVED
- 21 Feb 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Feb 2017 — REGISTERED-PRINCIPAL REGISTER
- 20 Jan 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Jan 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jan 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Jan 2017 — ASSIGNED TO LIE
- 16 Dec 2016 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Jul 2016 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Jul 2016 — NON-FINAL ACTION E-MAILED